Portugal
Medical devices sector wants extraordinary fee restricted to large companies
Publication: ECO
Author: Diogo Mendo Fernandes
Source published: 28/09/2026, 05:42:16 UTC
Briefing created: 28/09/2026, 07:17:19 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 28/09/2026, 07:11:25 UTC.
Briefings
Portuguese medical device suppliers face a 2027 transitional tax on public procurement, currently paid by the state to fund medical technologies. The Association of Portuguese Medical Device Enterprises (APORMED) is negotiating with parliament and the government to remove this 1.45 billion euro annual burden, which affects up to 4% of public invoices. While the tax has historically supported the National Health Service (SNS), APORMED argues it penalizes innovation and ignores the 15-40% cost increase from the Middle East war, which has not been passed to market prices. The proposal aims to phase out the tax by 2028, but the government's allocation of the collected revenue remains unclear, with funds currently held by the Ministry of Health without known spending guidelines.
Key points
- A 2027 transitional tax on public procurement for medical devices affects up to 4% of public invoices, currently paid by the state to fund technologies.
- APORMED is negotiating with parliament and the government to remove this 1.45 billion euro annual burden, arguing it penalizes innovation and ignores the 15-40% cost increase from the Middle East war.
Context and limitations
Coverage is limited to the 2026-2027 period; specific details on the 2028 removal timeline and the current allocation of the tax revenue remain uncertain.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 28/09/2026, 07:17:19 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeihey4gzn37u25df6atptmffsel3mq427hfurzuvsbjfp7oqxiu4g4